Essais liés4clinical trials
VilleKovinlocalisation
PaysSerbialocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05980949

Ouvrir le site du centre

Essais cliniques associés

4
MoléculeIndication / populationPhaseNCTTitreStatut
KarXT Alzheimer Phase 3 NCT05980949 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) RECRUITING
ITI-1284 Alzheimer Phase 2 NCT06651567 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia RECRUITING
ITI-1284 Alzheimer Phase 2 NCT06540833 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease RECRUITING
ACP-204 Alzheimer Phase 3 NCT06194799 ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study ENROLLING_BY_INVITATION